LC-MS/MS measurement of parathyroid hormone PTH (1-34): Use in studying oral PTH (1-34) administration and possible diagnostic application in pseudohypoparathyroidism.

Sulaiman Al Riyami, Jonathan C Y Tang (Lead Author), Hillel Galitzer, William Fraser

Research output: Contribution to conference › Poster › peer-review

4 Poster

4 results

Filter

2017

Development and Validation of a LC-MS/MS Assay for Quantification of Parathyroid Hormone (PTH 1-34) in human Plasma
Al Riyami, S., Tang, J. C. Y., Dutton, J., Washbourne, C., Galitzer, H. & Fraser, W., 10 Sept 2017.
Research output: Contribution to conference › Poster › peer-review

Open Access
File

52 Downloads (Pure)
Enhanced bioavailability and reduced pharmacokinetic variability of Oral PTH (1-34) in man
Burstein, G., Tang, J. C. Y., Rothner, A., Galitzer, H., Schwartz, P. & Fraser, W., 11 Sept 2017.
Research output: Contribution to conference › Poster › peer-review

Open Access
File

31 Downloads (Pure)
Measurements of Osteoanabolic agents PTH (1-34) and PTHrP (1-36) in therapeutic studies and clinical diagnostics
Al Riyami, S., Tang, J. C. Y., Galitzer, H. & Fraser, W., 10 Sept 2017.
Research output: Contribution to conference › Poster › peer-review

Open Access
File

16 Downloads (Pure)
2014

First in Man Studies of Pharmacokinetic Profiles of a Novel Oral PTH(1-34)
Tang, J., Galitzer, H., Washbourne, C., Piec, I., Wang, N., Burshtein, G., Phillip Schwartz, P., Caraco, Y., Ehud Arbit, E. & Fraser, W., 15 Sept 2014.
Research output: Contribution to conference › Poster › peer-review

Open Access
File

25 Downloads (Pure)